Lamictal Dispers 25 mg
As listed in the register: Lamictal Dispers 25 mg, kauwtabletten/dispergeerbare tabletten
25 mg · dispergeerbare tablet, kauwtablet
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Lamotrigine
- Made by
- GlaxoSmithKline B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Lamotrigine). It describes the substance, not this exact product.
The precise mechanism(s) by which lamotrigine exerts its anticonvulsant action are unknown.
In animal models designed to detect anticonvulsant activity, lamotrigine was effective in preventing seizure spread in the maximum electroshock (MES) and pentylenetetrazol (scMet) tests, and prevented seizures in the visually and electrically evoked after-discharge (EEAD) tests for antiepileptic activity.
Lamotrigine is metabolized predominantly by glucuronic acid conjugation; the major metabolite is an inactive 2-N-glucuronide conjugate.
The bioavailability is not affected by food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-04
Safety of the active substance
From the US prescribing label for the same active substance (Lamotrigine). It describes the substance, not this exact product.
WARNING: SERIOUS SKIN RASHES Lamotrigine can cause serious rashes requiring hospitalization and discontinuation of treatment.
- Lamotrigine is contraindicated in patients who have demonstrated hypersensitivity (e.g., rash, angioedema, acute urticaria, extensive pruritus, mucosal ulceration) to the drug or its ingredients [see Boxed Warning, Warnings and Precautions (5.1), (5.3) ].
- Hypersensitivity to the drug or its ingredients.
Most common adverse reactions (incidence ≥10%) in adults were dizziness, headache, diplopia, ataxia, nausea, blurred vision, somnolence, rhinitis, pharyngitis, and rash.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States59 matching products
Spain10 matching products
- CRISOMET 25 mg lamotrigina · comprimido masticable y dispersable
- LABILENO 25 mg lamotrigina · comprimido masticable y dispersable
- LAMICTAL Lamotrigina 25 mg · comprimido masticable y dispersable
- LAMOTRIGINA AUROBINDO 25 mg lamotrigina · comprimido dispersable
- LAMOTRIGINA AUROVITAS 25 mg · comprimido masticable y dispersable
- LAMOTRIGINA NORMON 25 MG · comprimido masticable y dispersable
- LAMOTRIGINA PHARMA COMBIX 25 mg · comprimido masticable y dispersable
- LAMOTRIGINA SANDOZ 25 mg · comprimido masticable y dispersable
France6 matching products
- LAMICTAL 25 mg · comprimé dispersible ou à croquer
- LAMOTRIGINE ARROW LAB 25 mg · comprimé dispersible ou à croquer
- LAMOTRIGINE BIOGARAN 25 mg · comprimé dispersible
- LAMOTRIGINE EG 25 mg · comprimé dispersible ou à croquer
- LAMOTRIGINE VIATRIS 25 mg · comprimé dispersible
- LAMOTRIGINE ZYDUS 25 mg · comprimé dispersible ou à croquer
Canada11 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | GlaxoSmithKline B.V. |
|---|---|
| Active substance | Lamotrigine |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 25 mg |
| Form | dispergeerbare tablet, kauwtablet |
| Classification | N03AX09 · Pain, sleep, mood, epilepsy and the brain |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Lamictal Dispers 25 mg, kauwtabletten/dispergeerbare tabletten |
| RVG | 19116 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- dispergeerbare tablet, kauwtablet3 products
25 mg3
25 mg · 3 companies
- Euro Registratie Collectief B.V.
- GlaxoSmithKline B.V. · this page
- Medcor Pharmaceuticals B.V.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.